Hannover Re in the news
Worldwide property casualty reinsurance
Tamtam found 20 recent articles about Hannover Re.
- Hannover Re stock: EUR 295.00, down 0.61% premarket
Hannover Re reported increased group net income and improved combined ratio for the first nine months of 2026, confirming its full-year guidance and preparing for an Investor Day on November 25 to detail 2027 outlook.
- Hannover Re net profit rises 6.9% to €2.1 bn, combined ratio improves
Hannover Re reported increased net profit and operating profit in the first nine months of 2026, driven by stronger property and casualty reinsurance results and higher investment income, maintaining its full-year guidance.
- Hannover Re stock gains support from stronger nine-month profit
Hannover Re's nine-month net income increased by 6.9% to EUR 2.1 billion, driven by strong performance in property and casualty reinsurance and investment income, keeping its full-year target unchanged.
- Versicherungsaktien gefragt: Munich Re, Hannover Rück und Allianz im Plus
European insurance stocks, including Munich Re, Hannover Re, Allianz, and Aviva, are showing positive performance.
- Hannover Rück Aktie im Fokus: Rekordgewinn voraus – nächstes Kursziel 345 Euro?
Hannover Re is expected to achieve record profits, with analysts projecting a share price target of 345 Euros.
- Hannover Rück Aktie im Fokus: Rekordgewinn & Chart-Check
Hannover Re is on track for a record profit of at least 2.7 billion EUR due to low major losses and strong investment performance, with its stock considered undervalued and showing a bullish chart setup.
- Hannover Rück SE 2026 Q3 - Results - Earnings Call Presentation (OTCMKTS:HVRRY) 2026-11-12
Hannover Re released its Q3 2026 earnings call presentation.
- Hannover Re stock gets new 2027 outlook ahead of investor day
Hannover Re will present its 2027 earnings outlook and medium-term strategy at its Investor Day on November 25, following strong first nine months results.
- Hannover Re: DZ Bank Research hält an seiner Buy-Empfehlung fest und erhöht das Kursziel von 314 EUR auf 326 EUR.
DZ Bank Research reaffirms its 'Buy' rating for Hannover Re and raises the price target to EUR 326.
- Hannover Re: Morgan Stanley stuft von Equal Weight auf Underweight herab und erhöht das Kursziel von 260 EUR auf 270 EUR.
Morgan Stanley downgraded Hannover Re to "Underweight" while simultaneously increasing its price target to 270 EUR.
- Transcript : Hannover Rück SE, Q3 2026 Earnings Call, Nov 09, 2026
Hannover Re conducted its Q3 2026 earnings call on November 9, 2026, to discuss the first nine months' financial results.
- Hannover Re stock weighs nat-cat growth option against renewal caution
Hannover Re evaluates growth in natural catastrophe reinsurance for 2027 based on market conditions and strong 2026 financial performance.
- RBC passt Prognosen für Hannover Re nach Q3-Ergebnissen an
RBC has adjusted its forecasts for Hannover Re after their Q3 results, and the document details several financial and ESG rating methodologies.
- Berenberg hebt Ziel für Hannover Rück auf 340 Euro - 'Buy'
Berenberg increased Hannover Re's price target to 340 euros and maintained a 'Buy' rating, anticipating the company will navigate market pressures to achieve higher profits and dividends.
- Berenberg: Hannover Re vor Wachstum trotz sich abschwächendem Rückversicherungsmarkt; Schätzungen und Kursziel angehoben
Berenberg increased its estimates and price target for Hannover Re, expecting growth despite a weakening reinsurance market.
- Hannover Re’s profits edge higher
Hannover Re reported a 7% increase in net income for the first nine months of 2026, primarily due to growth in property and casualty reinsurance operating profit, despite a slight dip in gross reinsurance revenue.
- Hannover Rück Aktie: Gute Zahlen, skeptisches Urteil – Qualität schon eingepreist?
Barclays maintains an 'underweight' rating for Hannover Re, citing that the company's quality is already priced into the stock, despite a good quarterly report and successful strategy.
- Hannover Re stock gains as profit target holds after nine months
Hannover Re reported increased nine-month earnings, driven by strong underwriting and investment income, while reaffirming its full-year profit target.
- UBS belässt Hannover Rück auf 'Buy' - Ziel 295 Euro
UBS maintained its 'Buy' rating for Hannover Re, citing good earnings development but a missed consensus on solvency ratio.
- RBC belässt Hannover Rück auf 'Sector Perform' - Ziel 280 Euro
RBC affirmed its 'Sector Perform' rating for Hannover Re with a 280 Euro target, noting the reinsurer's cautious stance in life, health, property, and casualty insurance ahead of its Capital Markets Day, with potential for positive surprise only in shareholder distributions.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Hannover Re?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies